Norvancomycin

Unknown Manufacturer

Indications

主要用于葡萄球菌（包括产酶株和耐甲氧西林株）、肠球菌（耐氨苄西林株）、难辨梭状芽胞杆菌等所致的系统感染和肠道感染，如心内膜炎、败血症，以及假膜性肠炎等。其余参阅万古霉素。

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

一种发酵生产去甲万古霉素的方法
CN 106801078 BApplicant: 华北制药集团新药研究开发有限责任公司Priority: 2016
CN
2 publications
Norvancomycin derivatives and preparation purifying method thereof
CN 105585617 AApplicant: INST OF MEDICINAL BIOTECHNOLOGY CHINESE ACAD OF MEDICAL SCIENCESPriority: 2016
CN
2 publications
Vancomycin and nor-vancomycin derivatives and their preparation process and use
CN 1827638 BApplicant: NORTH CHINA PHARMACEUTICAL GROUP CORPPriority: 2005
CN
Intraocular injection for treating infectious endophthalmitis
CN 101455836 AApplicant: CHENGHUA DAIPriority: 2009
CN
万古霉素类衍生物及其制备方法和药用用途
CN 103880930 BApplicant: 复旦大学Priority: 2014
CN
去甲万古霉素类二聚体衍生物及其制备方法和药用用途
CN 106317206 BApplicant: 复旦大学Priority: 2015
CN
株抗万古霉素单克隆抗体杂交瘤细胞株及其应用
CN 105200013 BApplicant: 江南大学Priority: 2015
CN
一种注射用盐酸去甲万古霉素制剂及其制备方法
CN 111388652 BApplicant: 华北制药股份有限公司Priority: 2020
CN
万古霉素衍生物及其制备方法和应用
CN 111620931 BApplicant: 苏州博源医疗科技有限公司Priority: 2020
CN
Method for purifying norvancomycin by using polymer filler
- CN 119350451 A
  Applicant: SHINEWAY PHARMACEUTICAL ZHANGJIAKOU CO LTDPriority: 2024
  CN
- CN 119529032 A
  Applicant: SHINEWAY PHARMACEUTICAL ZHANGJIAKOU CO LTDPriority: 2024
  CN